🔎 Trials Near Me

Akèy › Kasinòm epitelyal ovè › Massachusetts › Boston

Etid klinik pou Kasinòm epitelyal ovè nan Boston, MA

8 etid pou Kasinòm epitelyal ovè ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Isoquercetin in People With Ovarian Cancer

Ap rekriteFaz 2
  • Beth Israel Deaconess Medical Center (Data Collection Only), Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07303894

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Ap rekriteFaz 3
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Fanm · Mizajou Jul 2, 2026 · NCT06819007

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

Ap rekriteFaz 1
  • Site 0104, Boston
Laj 18 ak plis · Fanm · Mizajou Apr 7, 2026 · NCT04516447

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Ap rekriteFaz 1/2
  • Massachusetts General Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Mar 27, 2026 · NCT06395519

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Ap rekriteFaz 2
  • Massachusetts General Hospital, Boston
Laj 18 ak plis · Fanm · Mizajou Dec 23, 2025 · NCT06690775

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Ap rekriteEtid obsèvasyon
  • Massachusetts General Hospital, Boston
Laj 30 ak plis · Fanm · Mizajou Sep 16, 2025 · NCT04794322

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Ap rekriteFaz 1
  • Dana Farber/Partners Cancer Care Inc, Boston
Laj 18 ak plis · Tout sèks · Mizajou Aug 15, 2025 · NCT04429542

Etid Kasinòm epitelyal ovè nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.